FERRACIN, Manuela
 Distribuzione geografica
Continente #
NA - Nord America 10.151
AS - Asia 4.760
EU - Europa 2.671
SA - Sud America 693
AF - Africa 103
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 5
Totale 18.400
Nazione #
US - Stati Uniti d'America 9.937
SG - Singapore 1.877
CN - Cina 1.134
BR - Brasile 529
VN - Vietnam 515
DE - Germania 509
IT - Italia 454
UA - Ucraina 389
HK - Hong Kong 367
GB - Regno Unito 298
TR - Turchia 298
FI - Finlandia 238
PL - Polonia 153
FR - Francia 141
SE - Svezia 134
BD - Bangladesh 113
RU - Federazione Russa 106
CA - Canada 104
JP - Giappone 101
IN - India 86
MX - Messico 85
ID - Indonesia 71
AR - Argentina 67
NL - Olanda 57
ZA - Sudafrica 35
ES - Italia 33
IQ - Iraq 33
AT - Austria 29
BE - Belgio 28
RO - Romania 27
CO - Colombia 24
EC - Ecuador 20
LT - Lituania 20
PK - Pakistan 19
SA - Arabia Saudita 18
CL - Cile 17
UZ - Uzbekistan 17
AU - Australia 16
TN - Tunisia 16
PH - Filippine 15
CZ - Repubblica Ceca 14
EG - Egitto 12
VE - Venezuela 12
IR - Iran 11
KR - Corea 11
MY - Malesia 11
CH - Svizzera 9
JM - Giamaica 9
DZ - Algeria 8
KE - Kenya 8
MA - Marocco 8
NP - Nepal 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
JO - Giordania 6
LB - Libano 6
OM - Oman 6
PY - Paraguay 6
PE - Perù 5
TH - Thailandia 5
AZ - Azerbaigian 4
BO - Bolivia 4
ET - Etiopia 4
GR - Grecia 4
IE - Irlanda 4
CR - Costa Rica 3
DO - Repubblica Dominicana 3
EU - Europa 3
GT - Guatemala 3
HN - Honduras 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LV - Lettonia 3
NO - Norvegia 3
RS - Serbia 3
SN - Senegal 3
TW - Taiwan 3
DK - Danimarca 2
EE - Estonia 2
HR - Croazia 2
IL - Israele 2
KW - Kuwait 2
LY - Libia 2
MU - Mauritius 2
PA - Panama 2
SR - Suriname 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
CI - Costa d'Avorio 1
GN - Guinea 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 18.392
Città #
Singapore 1.108
Ashburn 1.083
Fairfield 1.070
Woodbridge 983
San Jose 610
Houston 609
Chandler 461
Jacksonville 437
Seattle 429
Ann Arbor 420
Santa Clara 399
Beijing 372
Hong Kong 355
Wilmington 348
Cambridge 332
Izmir 184
Munich 181
Los Angeles 171
Ho Chi Minh City 166
Warsaw 148
New York 135
Dallas 131
Nanjing 126
Ferrara 116
Hanoi 113
Princeton 100
Helsinki 95
Tokyo 91
San Diego 89
Lauterbourg 78
Boardman 74
Milan 65
São Paulo 65
Shanghai 57
Jakarta 55
Orem 54
Mexico City 49
London 48
Turku 46
Nanchang 42
Bremen 41
Chicago 41
Falls Church 41
Council Bluffs 39
Montreal 35
Dearborn 34
Buffalo 32
Tianjin 32
Atlanta 31
Brooklyn 31
Toronto 31
Hebei 28
Denver 27
Shenyang 27
The Dalles 27
Brussels 26
Changsha 25
Frankfurt am Main 25
Haiphong 25
Johannesburg 25
Hefei 23
Jiaxing 23
Phoenix 22
Addison 21
Amsterdam 21
Da Nang 20
Poplar 20
Stockholm 20
Ankara 19
Boston 19
Jinan 19
Falkenstein 18
Manchester 18
Mountain View 18
Nuremberg 18
Rio de Janeiro 18
Rome 18
Chennai 17
Hangzhou 17
San Francisco 17
Timisoara 17
Vienna 17
Baghdad 16
Bologna 15
Moscow 15
Guangzhou 14
Norwalk 14
Tashkent 14
Washington 14
Columbus 13
Dong Ket 13
Kunming 13
Philadelphia 13
Hải Dương 12
Naples 12
Belo Horizonte 11
Curitiba 11
Mumbai 11
Ningbo 11
Querétaro 11
Totale 12.771
Nome #
Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma 372
Absolute quantification of cell-free microRNAs in cancer patients 333
Mesenchymal Progenitors Aging Highlights a miR-196 Switch Targeting HOXB7 as Master Regulator of Proliferation and Osteogenesis 325
MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab 312
Diagnostic and prognostic microRNAs in the serum of breast cancer patients measured by droplet digital PCR 303
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 291
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer 284
Serum From Advanced Heart Failure Patients Promotes Angiogenic Sprouting and Affects the Notch Pathway in Human Endothelial Cells 277
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 269
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 258
Circulating microRNAs, MIR-939, MIR-595, MIR-519d and MIR-494, identify cirrhotic patients with HCC 243
miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression 243
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 241
microRNAome Expression in Chronic Lymphocytic Leukemia: Comparison with Normal B-cell Subsets and Correlations with Prognostic and Clinical Parameters 237
A transcriptome-wide approach reveals the key contribution of NFI-A in promoting erythroid differentiation of human CD34(+) progenitors and CML cells 235
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues 233
Characterisation of peripheral blood mononuclear cell microRNA in early onset psoriatic arthritis 232
Investigations on microRNAs in human chronic lymphocytic leukemia and control of cancer-associated molecular pathways 230
MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis 227
Quantification of circulating miRNAs by droplet digital PCR: Comparison of EvaGreen- and TaqMan-based chemistries 226
A tumor-promoting mechanism mediated by retrotransposon-encoded reverse transcriptase is active in human transformed cell lines 223
A microRNA signature of hypoxia 218
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia 215
Over-expression of the miR-483-3p overcomes the miR-145/TP53 pro-apoptotic loop in hepatocellular carcinoma 215
Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas 209
Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD 208
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 207
Espressione dei MicroRNA nei carcinomi mammari 201
Clinical Monoclonal B lymphocytosis versus Rai 0 Chronic Lymphocytic Leukemia: a Comparison of Cellular, Cytogenetic, Molecular, and Clinical Features 194
Heart rate reduction with ivabradine in the early phase of atherosclerosis is protective in the endothelium of ApoE-deficient mice 194
Significance of Aberrant Expression of MicroRNAs in Cancer Cells 193
MicroRNA expression changes during human leukemic HL-60 cell differentiation induced by 4-hydroxynonenal, a product of lipid peroxidation 193
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer 191
Expression Profiles of the Internal Jugular and Saphenous Veins: Focus on Hemostasis Genes 190
Tumor suppressor functions of ARLTS1 in lung cancers 189
Mutated beta-catenin evades a microRNA-dependent regulatory loop 188
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas 185
Extensive modulation of a set of microRNAs in primary glioblastoma 185
MicroRNA expression profile in peripheral blood cells of psoriatic arthritis 181
Altered miRNA expression in T regulatory cells in course of multipla sclerosis 180
MicroRNA deregulation in human thyroid papillary carcinomas 178
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance 176
The Role of Micro-RNAs in Rheumatic Diseases: An Update 173
MicroRNAs in cancer (an overview) 173
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia 172
Modulation of mismatch repair and genomic stability by miR-155 172
MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells 171
Oncogenic role of miR-483-3p at the IGF2/483 locus 170
DNA methylation of shelf, shore and open sea CpG positions distinguish high microsatellite instability from low or stable microsatellite status colon cancer stem cells 170
Genetic dynamics in untreated CLL patients with either stable or progressive disease: A longitudinal study 170
miR-126&126* Restored Expressions Play a Tumor Suppressor Role by Directly Regulating ADAM9 and MMP7 in Melanoma 169
A microRNA expression signature of human solid tumors defines cancer gene targets 169
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality 169
Micro-RNA profiling in kidney and bladder cancers 165
MicroRNA Expression Profiling and Its Clinical Impact in Breast Cancer 163
Circulating microRNAs and isomiRs as biomarkers for the initial insult and epileptogenesis in four experimental epilepsy models: The EPITARGET study 162
MicroRNA profiling of primary pulmonary enteric adenocarcinoma in members from the same family reveals some similarities to pancreatic adenocarcinoma-a step towards personalized therapy 159
Regulation of microRNA expression: the hypoxic component 158
P2X7 promotes metastatic spreading and triggers release of miRNA-containing exosomes and microvesicles from melanoma cells 158
MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndrome 157
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs 157
Non-coding RNAs change their expression profile after Retinoid induced differentiation of the promyelocytic cell line NB4 153
Hemostasis gene expression of the internal jugular and saphenous veins 153
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias 152
Principles of MicroRNA involvement in breast cancer 151
Isolation and characterization of CD146+ multipotent mesenchymal stromal cells 148
Differential cytogenomics and miRNA signature of the Acute Myeloid Leukaemia Kasumi-1 cell line CD34+38- compartment 147
Micro-markers: microRNAs in cancer diagnosis and prognosis 146
MicroRNAs and Their Role in Cancer 145
Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway. 140
miRNA signature predicts survival of Ewing’s sarcoma patients and miR34a directly influences cell chemosensitivity and malignancy 139
HINCUTs in cancer: hypoxia-induced noncoding ultraconserved transcripts 139
OncomiR detection in circulating body fluids: A PDMS microdevice perspective 139
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma 136
MiR-15a and miR-16-1 cluster functions in human leukemia 136
First Report of Circulating MicroRNAs in Tumour Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS) 134
MicroRNAs as biomarker of Parkinson disease? Small but mighty. 132
miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs 128
MicroRNA coinvolti nello sviluppo del carcinoma epatocellulare. Identificazione delle proteine bersaglio. 125
MicroRNAs: toward the clinic for breast cancer patients 125
How to fish a good micro-marker out from a worthless lake: The case of cell-free miR-181a-5p and breast cancer 119
MicroRNA gene expression deregulation in human breast cancer 116
Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155. 115
Karyotype-specific microRNA signature in chronic lymphocytic leukemia 113
null 111
Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas 110
Familial cancer associated with a polymorphism in ARLTS1 107
The methylator phenotype in microsatellite stable colorectal cancers is characterized by a distinct gene expression profile 104
Involvement of the Inconstant Bursa of the Fifth Metatarsophalangeal Joint in Psoriatic Arthritis: A Clinical and Ultrasonographic Study 103
null 101
microRNAs and Inflammatory Immune Response in SARS-CoV-2 Infection: A Narrative Review 101
Progetto triennale AIRC (MFAG 2011). Titolo: Circulating microRNAs as cancer-specific biomarkers 100
null 96
null 94
null 94
null 93
null 91
null 89
null 89
null 89
Totale 17.544
Categoria #
all - tutte 78.006
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.492
Totale 81.498


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021117 0 0 0 0 0 0 0 0 0 0 0 117
2021/20221.191 54 107 107 31 56 74 78 57 39 84 113 391
2022/20231.051 114 77 35 156 161 166 40 76 121 12 47 46
2023/2024561 70 63 23 8 43 111 27 35 10 22 9 140
2024/20252.571 43 46 181 121 316 251 118 143 482 238 362 270
2025/20266.573 673 211 522 842 887 417 869 413 680 607 325 127
Totale 18.588